Product Information
BUSPIRONE HCL 10 MG TABLET is a generic product labeled by Accord Healthcare Inc., priced at $0.0296 per EA under NDC 16729020216. Its NADAC has been published 490 times since Jan 4, 2017.
FDA first approved this application on Dec 30, 2014. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
10 mg/1
Manufacturer
Accord Healthcare Inc.NDC
16729020216
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
5/20/2026
Active Ingredients
BUSPIRONE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA202557FDA Approved
12/30/2014
TE Code
AB
On Market Since
12/15/2016
Price Statistics
The NADAC for BUSPIRONE HCL 10 MG TABLET has been published 490 times since Jan 4, 2017, and over the history we have for it it has declined 54.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0296 per EA |
|---|---|
| All-time high | $0.0655 (Jan 11, 2017) |
| All-time low | $0.0258 (Nov 20, 2024) |
| 52-week high | $0.0316 |
| 52-week low | $0.0293 |
| Median price | $0.0405 |
| Average price | $0.0419 |
| Largest weekly change | +24.0% (Aug 21, 2024) |
| Weeks tracked | 490 |
| Tracking since | Jan 4, 2017 |
1W
N/A
1M
N/A
3M
N/A
6M
+1.3%
1Y
-6.2%
3Y
-20.9%
5Y
-24.4%
All
-54.8%
Last surveyed May 20, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 9 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 6% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of BUSPIRONE HCL 10 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for BUSPIRONE HCL 10 MG TABLET, manufactured by Accord Healthcare Inc., is $0.0296 per EA (NDC 16729020216), effective May 20, 2026.
How has the price of BUSPIRONE HCL 10 MG TABLET changed over time?
Over the history we have for it, the NADAC for BUSPIRONE HCL 10 MG TABLET has declined 54.8%. It has been tracked across 490 weekly CMS publications since Jan 4, 2017.
What are the highest and lowest recorded NADAC prices for BUSPIRONE HCL 10 MG TABLET?
Since Jan 4, 2017, the NADAC for BUSPIRONE HCL 10 MG TABLET has ranged from a low of $0.0258 (Nov 20, 2024) to a high of $0.0655 (Jan 11, 2017), with a median of $0.0405 per EA.
Are there cheaper alternatives to BUSPIRONE HCL 10 MG TABLET?
Yes. 9 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, BUSPIRONE HCL 10 MG TABLET, is $0.0279 per EA — about 6% below BUSPIRONE HCL 10 MG TABLET.
Who manufactures BUSPIRONE HCL 10 MG TABLET?
BUSPIRONE HCL 10 MG TABLET (NDC 16729020216) is labeled by Accord Healthcare Inc., and CMS classifies it as a generic product.